A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Clinical trial NCT02559817 · TERMINATED
Trial details
- NCT number
- NCT02559817
- Sponsor
- Forest Laboratories
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2019-08-30
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.